Marchiafava-Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions

P Ménégon1, I Sibon, C Pachai

  • 1Service de Neuroradiologie, Hôpital Pellegrin, CHU Bordeaux, France. patrice.menegon@chu-bordeaux.fr

Neurology
|August 10, 2005
PubMed

Insights

Diagnosing Marchiafava-Bignami disease (MBD) is challenging. Diffusion-weighted imaging (DWI) reveals corpus callosum abnormalities, with restricted diffusion linked to worse outcomes and higher mortality in acute MBD cases.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Marchiafava-Bignami disease (MBD) is a rare neurological disorder.
  • Clinical diagnosis of MBD can be challenging.
  • Acute demyelination of the corpus callosum is a hallmark of MBD.

Purpose of the Study:

  • To evaluate the utility of MR diffusion-weighted imaging (DWI) in diagnosing acute MBD.
  • To correlate DWI findings with clinical outcomes in MBD patients.

Main Methods:

  • Retrospective analysis of six acute MBD cases.
  • Utilized MR diffusion-weighted imaging (DWI).
  • Assessed apparent diffusion coefficient (ADC) restriction in the corpus callosum and cortical lesions.

Main Results:

  • Apparent diffusion coefficient (ADC) restriction was observed in the corpus callosum.
  • Cortical lesions also showed ADC restriction.
  • ADC restriction in these areas correlated with increased mortality and severe cognitive deficits.

Conclusions:

  • MR diffusion-weighted imaging (DWI) is a valuable tool for diagnosing acute MBD.
  • Diffusion abnormalities in the corpus callosum and cortex are associated with poor prognosis in MBD.
  • DWI findings can help predict mortality and cognitive sequelae in MBD.